Table 6.
Cox regression of clinical-pathological variables regarding overall survival in vulvar carcinoma patients.
| Variable | Significance | Hazard Ratio of Exp (B) | Lower 95% Confidence Interval of Exp (B) |
Upper 95% Confidence Interval of Exp (B) |
|---|---|---|---|---|
| PPARγ+/COX-2 | 0.001 | 2.615 | 1.460 | 4.683 |
| pT | 0.613 | 1.195 | 0.598 | 2.388 |
| pN | 0.85 | 1.006 | 0.999 | 1.013 |
| Grading | 0.012 | 1.738 | 1.129 | 2.676 |
| FIGO | 0.098 | 1.453 | 0.933 | 2.263 |
| p16 status | 0.002 | 0.380 | 0.208 | 0.694 |
PPARγ+/COX-2 = expression of PPARγ and/or COX-2 in cytoplasm (IRS), pT = tumor stage, pN = nodal stage, FIGO = Classification of the International Federation of Gynecology and Obstetrics.